Onconova Therapeutics, Inc. (ONTX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	8-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	38.8	0.0	0.0	0.0	0.0	0.0	0.0	19.8
Accounts receivable, net	0.0				0.0	0.1	0.0	1.5
Other current assets	0.6	55.4	19.8	23.5	17.7	4.8	23.0	27.0
Total current assets	39.3	55.4	19.8	23.5	17.8	4.9	23.1	48.3
Property, plant, and equipment, net	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.2
Other fixed assets	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0
Total assets	39.4	55.5	20.0	23.7	17.9	5.0	23.2	23.4

Accounts payable	3.9	2.8	4.8	4.3	4.0	6.2	5.3	3.4
Accrued expenses	4.0	3.1	5.0	3.8	4.2	3.3	4.4	3.7
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred revenues	0.2						0.5	0.5
Other current liabilities		0.2	0.2	0.2	0.2	0.5
Total current liabilities	8.0	6.1	10.0	8.3	8.4	10.0	10.2	7.6
Other liabilities	3.0	3.2	3.8	3.8	4.1	5.9	7.9	5.0
Total liabilities	11.1	9.4	13.8	12.1	12.5	15.8	18.1	12.6

Shareholders' equity [+]	28.3	46.1	6.2	11.6	5.4	-10.9	5.1	10.8
Paid-in capital	491.8	490.6	434.6	413.9	387.2	350.6	342.5	328.6
Retained earnings	-463.7	-444.7	-428.6	-403.4	-381.9	-362.3	-338.2	-318.6
Tangible shareholders' equity	28.3	46.1	6.2	11.6	5.4	-10.9	5.1	10.8